Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States
Samuel B Graitcer1, Larisa Gubareva, Laurie Kamimoto
1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Abstract:
During April 2009-June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and had received oseltamivir before specimen collection (89%). No evidence was found for community circulation of resistant viruses; only 4 (unlinked) patients had no oseltamivir exposure.
Insights
Oseltamivir-resistant pandemic (H1N1) 2009 virus was found in 0.5% of cases. Most resistant infections occurred in immunocompromised patients previously treated with oseltamivir, with no evidence of community spread.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Influenza A (H1N1)pdm09 virus emerged in 2009.
- Oseltamivir is a key antiviral medication for influenza treatment.
- Antiviral resistance is a growing public health concern.
Purpose of the Study:
- To determine the prevalence of oseltamivir resistance in pandemic (H1N1) 2009 viruses.
- To identify risk factors associated with oseltamivir-resistant infections.
Main Methods:
- Analysis of pandemic (H1N1) 2009 viruses submitted to a US surveillance system between April 2009 and June 2010.
- Phenotypic or genotypic testing for oseltamivir resistance.
- Review of patient clinical data, including immunocompromised status and oseltamivir treatment history.
Main Results:
- Thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses exhibited oseltamivir resistance.
- The majority of patients (76%) with resistant infections were severely immunocompromised.
- Most patients with resistant infections (89%) had received oseltamivir prior to specimen collection.
Conclusions:
- Oseltamivir resistance in pandemic (H1N1) 2009 viruses was low during the study period.
- Severely immunocompromised individuals with prior oseltamivir exposure are at higher risk for resistant infections.
- No evidence of widespread community circulation of oseltamivir-resistant pandemic (H1N1) 2009 viruses was observed.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
03:53Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
Related Concept Videos
Influenza
Infectious Diseases and Their Occurrence
Atypical Pneumonia
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Coronavirus
